Reduced volume formulation of glatiramer acetate and methods...

Details Reduced volume formulation of glatiramer acetate and methods... Reduced volume formulation of glatiramer acetate and methods...

A - Human Necessities

61

K

A61K 47/10 (2006.01) A61K 9/08 (2006.01) A61K 38/16 (2006.01) A61M 5/178 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2697570

A method for reducing frequency of relapses in a human patient afflicted with relapsing-remitting multiple sclerosis (RRMS) comprising administering to the patient 0.5ml of an aqueous pharmaceutical solution of 20mg glatiramer acetate and 20mg mannitol.

Méthode permettant de réduire la fréquence des rechutes chez un patient atteint de sclérose en plaques rémittente comprenant l'administration de 0,5 ml d'une solution aqueuse pharmaceutique de 20 mg d'acétate de glatiramère et de 20 mg de mannitol.

Affiliated with

Also associated with

Rating

Reduced volume formulation of glatiramer acetate and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduced volume formulation of glatiramer acetate and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduced volume formulation of glatiramer acetate and methods... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1427009